IRCT20221019056244N1
The effect of letrozole and N-acetylcysteine in the treatment of infertility in patients with polycystic ovary syndrome
Comparison of the effect of letrozole with N-acetylcysteine on the expression levels of genes involved in glucose metabolism and the proliferation of cumulus cells in patients with polycystic ovarian syndrome.
Tabriz University of Medical Sciences·Phase 2·Iranian Registry Of Clinical Trial·drugRecruiting
Study focus
- Disease/Condition
- Polycystic ovarian syndrome
- Study type
- Interventional
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- Tabriz University of Medical Sciences
- Location
- Iran
Timeline & enrollment
- Phase
- Phase 2
- Start date
- Mar 21, 2023
- End date
- N/A
ICD-10 classifications
Polycystic ovarian syndromeOvarian dysfunction, unspecifiedOvarian dysfunctionOther ovarian dysfunctionOther and unspecified ovarian cysts
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT20221019056244N1
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT20221019056244N1 through Pure Global AI's free database. This Phase 2 trial is sponsored by Tabriz University of Medical Sciences and is currently Recruiting. The study focuses on Polycystic ovarian syndrome.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.